Myelodysplastic Syndrome with Excess Blasts-1 2
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndrome with Excess Blasts-1 2.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Allogenic NK Cell Transfusion Azacitidine MDS-EB [Phase 1, Phase 2]
Clinical trial update investigating allogeneic NK cell transfusion with azacitidine in MDS-EB, spanning Phase 1 and Phase 2.